期刊
NATURE REVIEWS CLINICAL ONCOLOGY
卷 10, 期 1, 页码 27-40出版社
NATURE PORTFOLIO
DOI: 10.1038/nrclinonc.2012.196
关键词
-
类别
资金
- Center for Translational Molecular Medicine framework (AIR FORCE)
- European Union
- QuIC-ConCePT
- Innovative Medicine Initiative Joint Undertaking
- Dutch Cancer Society [KWF UM 2011-5020, KWF UM 2009-4454]
- NATIONAL CANCER INSTITUTE [U01CA143062] Funding Source: NIH RePORTER
With the emergence of individualized medicine and the increasing amount and complexity of available medical data, a growing need exists for the development of clinical decision-support systems based on prediction models of treatment outcome. In radiation oncology, these models combine both predictive and prognostic data factors from clinical, imaging, molecular and other sources to achieve the highest accuracy to predict tumour response and follow-up event rates. In this Review, we provide an overview of the factors that are correlated with outcome-including survival, recurrence patterns and toxicity-in radiation oncology and discuss the methodology behind the development of prediction models, which is a multistage process. Even after initial development and clinical introduction, a truly useful predictive model will be continuously re-evaluated on different patient datasets from different regions to ensure its population-specific strength. In the future, validated decision-support systems will be fully integrated in the clinic, with data and knowledge being shared in a standardized, instant and global manner. Lambin, P. et al. Nat. Rev. Clin. Oncol. 10, 27-40 (2013); published online 20 November 2012; doi:10.1038/nrclinonc.2012.196
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据